Evidence map›Paper›PMID 36851640›Full record

ArticleViruses2023

Development and Evaluation of Bacteriophage Cocktail to Eradicate Biofilms Formed by an Extensively Drug-Resistant (XDR)

Medhavi Vashisth, Anu Bala Jaglan, Shikha Yashveer, Priya Sharma, Priyanka Bardajatya, Nitin Virmani, Bidhan Chand Bera, Rajesh Kumar Vaid, Taruna Anand

Abstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Phage-Based Approaches to ChronicAntibiotics (Basel, Switzerland) · 2026
    Review
  4. A broad-host-range inhalable phage cocktail for treatment of multidrug-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Phage Cocktail againstInternational journal of molecular and cellular medicine · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Medhavi VashisthICAR-National Research Centre on Equines, Hisar 125001, India.ORCID 0000-0002-9896-1891
Anu Bala JaglanICAR-National Research Centre on Equines, Hisar 125001, India.
Shikha YashveerDepartment of Molecular Biology and Biotechnology, College of Biotechnology, Chaudhary Charan Singh Haryana Agricultural University, Hisar 125004, India.
Priya SharmaICAR-National Research Centre on Equines, Hisar 125001, India.
Priyanka BardajatyaICAR-National Research Centre on Equines, Hisar 125001, India.
Nitin VirmaniICAR-National Research Centre on Equines, Hisar 125001, India.
Bidhan Chand BeraICAR-National Research Centre on Equines, Hisar 125001, India.
Rajesh Kumar VaidICAR-National Research Centre on Equines, Hisar 125001, India.ORCID 0000-0002-7554-5238
Taruna AnandICAR-National Research Centre on Equines, Hisar 125001, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extensive and multiple drug resistance in

Indexed as

BacteriophagesCross InfectionBiofilmsBiological AssayHumansPseudomonas aeruginosabacteriophagebiofilmextensively drug resistant (XDR)phage cocktailPseudomonas aeruginosa

Identifiers

PMID36851640
PMCPMC9965693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.